Abstract

Spinal muscular atrophy (SMA) is a neurodegenerative disorder that affects motor neurons, primarily in young children. SMA is caused by mutations in the Survival Motor Neuron 1 (SMN1) gene. SMN functions in the assembly of spliceosomal RNPs and is well conserved in many model systems including mouse, zebrafish, fruit fly, nematode, and fission yeast. Work in Drosophila has focused on the loss of SMN function during larval stages, primarily using null alleles or strong hypomorphs. A systematic analysis of SMA-related phenotypes in the context of moderate alleles that more closely mimic the genetics of SMA has not been performed in the fly, leading to debate over the validity and translational value of this model. We, therefore, examined 14 Drosophila lines expressing SMA patient-derived missense mutations in Smn, with a focus on neuromuscular phenotypes in the adult stage. Animals were evaluated on the basis of organismal viability and longevity, locomotor function, neuromuscular junction structure, and muscle health. In all cases, we observed phenotypes similar to those of SMA patients, including progressive loss of adult motor function. The severity of these defects is variable and forms a broad spectrum across the 14 lines examined, recapitulating the full range of phenotypic severity observed in human SMA. This includes late-onset models of SMA, which have been difficult to produce in other model systems. The results provide direct evidence that SMA-related locomotor decline can be reproduced in the fly and support the use of patient-derived SMN missense mutations as a comprehensive system for modeling SMA.

Highlights

  • Spinal Muscular Atrophy (SMA) is a neurodegenerative disease that primarily affects motor neurons in the anterior horn of the spinal cord and is a leading genetic cause of death among infants (Pearn, 1980)

  • To maximize the range of phenotypic severity examined in this study, Drosophila lines carrying transgenic insertions of 14 different Smn alleles were examined, in addition to the Oregon R (OR) wild type lab strain

  • We will refer to these transgenic lines by the amino acid substitution produced in the fly Survival Motor Neuron (SMN) protein (D20V, for example)

Read more

Summary

Introduction

Spinal Muscular Atrophy (SMA) is a neurodegenerative disease that primarily affects motor neurons in the anterior horn of the spinal cord and is a leading genetic cause of death among infants (Pearn, 1980). The diaphragm becomes involved in later stages, leading to difficulty breathing and persistent respiratory infection that is a typical cause of death (Crawford, 2017). Spinal Muscular Atrophy in Fly cases or in adulthood in the least severe. This spectrum has been subdivided into different ‘‘types’’ of SMA (Darras and Finkel, 2017; Talbot and Tizzano, 2017) based on age of onset: Type 0 (in utero), Type I (first 6 months), Type II (7–18 months), Type III (childhood onset after 18 months), and Type IV (adult onset). Motor neurons are the most dramatically impacted cell-type in SMA, other tissues including the musculature, cardiovascular system, liver, pancreas, gastrointestinal tract, and immune system are affected (Perez-Garcia et al, 2017)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call